McKesson Corp. (MCK) News

McKesson Corp. (MCK): $336.42

2.94 (+0.88%)

POWR Rating

Component Grades













Filter MCK News Items

MCK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MCK News Highlights

  • For MCK, its 30 day story count is now at 110.
  • Over the past 25 days, the trend for MCK's stories per day has been choppy and unclear. It has oscillated between 1 and 41.
  • The most mentioned tickers in articles about MCK are DRUG, NXGN and PAY.

Latest MCK News From Around the Web

Below are the latest news stories about Mckesson Corp that investors may wish to consider to help them evaluate MCK as an investment opportunity.

Completed Settlements Signal Opioid Litigation Is Drawing to a Close

Shares of Johnson & Johnson, AmerisourceBergen, McKesson, and Cardinal Health jumped Friday morning.

Yahoo | February 25, 2022

Are These Medical Stocks a Great Value Stocks Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo | February 25, 2022

Chemed (CHE) Q4 Earnings Surpass Estimates, Revenues Miss

Chemed (CHE) reports better-than-expected earnings for the fourth quarter, with a robust performance by the Roto-Rooter arm driving the top line.

Yahoo | February 25, 2022

Myriad Genetics (MYGN) Reports Loss in Q4, Gross Margin Improves

Strength in Myriad Genetics' (MYGN) Molecular Diagnostic segment has drove Q4 sales despite a challenging business environment.

Yahoo | February 25, 2022

Teleflex (TFX) Q4 Earnings & Revenues Top Estimates, Margins Up

Strong segmental performance in the domestic and international markets is driving Teleflex's (TFX) fourth-quarter top line.

Yahoo | February 25, 2022

Distributors Approve Opioid Settlement Agreement

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas, February 25, 2022--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that each company has independently determined that there is sufficient participation by states and litigating political subdivisions to proceed with a comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities.

Yahoo | February 25, 2022

Insulet (PODD) Q4 Earnings Surpass Estimates, Margins Up

Insulet's (PODD) fourth-quarter 2021 revenues improved year over year on a strong performance of Omnipod, both in U.S. and international markets.

Yahoo | February 24, 2022

NuVasive (NUVA) Q4 Earnings Miss Estimates, Gross Margin Up

Continued strong international performance and introduction of products drove NuVasive's (NUVA) revenues in the fourth quarter of 2021.

Yahoo | February 24, 2022

Amedisys (AMED) Q4 Earnings Top Estimates, Margins Decline

Robust performances by the Home Health and Hospice segments drove Amedisys' (AMED) fourth-quarter top line.

Yahoo | February 24, 2022

Broyhill Asset Management - McKesson Corp: Change Hands At Half The Market's Valuation?

The following segment was excerpted from this fund letter. McKesson Corp (MCK) Shares of McKesson tacked on another 23% during the second half. Even after gaining 44% for the full year, the stock still trades at a 50% discount to the market. Like our Dollar Tree investment, investor sentiment around...

Fund Letter Stock Ideas on Seeking Alpha | February 23, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5136 seconds.